Is Dobutamine Hydrochloride Injection in shortage?
Yes. Dobutamine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why it’s in shortage
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)
Maker contact: 888-229-0001
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)
Maker contact: 888-229-0001
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)
Maker contact: 888-229-0001
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10)
Maker contact: 844-646-4398
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10)
Maker contact: 844-646-4398
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10)
Maker contact: 844-646-4398
- Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)
Maker contact: 844-646-4398
- Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)
Maker contact: 844-646-4398
- Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)
Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)
Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988
Maker contact: Slate Run Pharmaceuticals, LLC: 844-529-8988
FDA recalls of Dobutamine Hydrochloride
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Dobutamine Hydrochloride Injection:
- Pfizer Inc. recalls DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only,
- Hospira Inc. recalls DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira Inc.,
- Hospira Inc. recalls DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL
Dobutamine Hydrochloride Injection shortage questions
Is Dobutamine Hydrochloride Injection in shortage?
Yes. Dobutamine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Oct 2, 2026.
Why is there a Dobutamine Hydrochloride Injection shortage?
FDA records the reason as: Other.
What should I do if I can’t get Dobutamine Hydrochloride Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.